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Purpose: Low estimated glomerular filtration rate (eGFR) (<60 mL/min/1.73 m2) is a recognized 
risk factor for pneumonia in general population. While pneumonia is common after stroke, the 
association between levels of eGFR and pneumonia in stroke patient population has not yet 
been examined thoroughly.
Patients and methods: Using data of 10,329 patients from the Norfolk and Norwich Stroke 
Registry between January 2003 and April 2015, we examined the association of poststroke 
pneumonia (in-hospital and after discharge) with low eGFR and when eGFR is divided into the 
complete spectrum of clinically relevant categories; (≥90) (ref.), 60–89, 45–59, 30–44, 15–30, 
and <15 mL/min/1.73 m2).
Results: In all, 1,519 (14.7%) developed in-hospital pneumonia and 1,037 (12.9%) developed 
pneumonia after hospital discharge. In age- and sex-adjusted model, low eGFR was associated 
with in-hospital pneumonia (subdistribution hazard ratio (sHR): 1.13; 95% CI: 1.01–1.25) and 
pneumonia after discharge (sHR: 1.20; 95% CI: 1.07–1.38). In fully adjusted model, association 
remained significant for pneumonia after hospital discharge. When eGFR was categorized in all 
clinically relevant categories, association with in-hospital pneumonia tended to be “U” shaped 
(eg, compared to eGFR ≥90, sHR for 60–89 was 0.78; 95% CI: 0.62–0.99 and for <15 was 1.06; 
95% CI: 0.71–1.60) and association with pneumonia after discharge tended to increase with 
decline in eGFR level such that risk was almost two fold higher at eGFR <15 (sHR: 1.85; 95% 
CI: 1.01–3.51). Association for in-hospital pneumonia was driven mainly by aspiration pneu-
monia, whereas association in stroke survivors was predominantly for nonaspiration pneumonia.
Conclusion: In stroke patients, low eGFR at admission was associated with pneumonia, par-
ticularly severely reduced eGFR with nonaspiration pneumonia after hospital discharge. eGFR 
could form the basis for identifying patients at high risk of poststroke pneumonia.
Keywords: stroke, eGFR, prognosis, epidemiology
Introduction
Pneumonia is a common complication after stroke; up to a third of stroke patients 
suffer from pneumonia.1–3 For early identification and appropriate management, pre-
vious studies have identified a number of factors including older age, dysarthria, and 
modified Rankin score as factors that are associated with pneumonia after stroke.4–6 
Although these factors have been helpful in identifying patients at risk of pneumonia, a 
number of the high-risk patients still remain unidentified.4 Moreover, these factors are 
predominantly identified for in-hospital pneumonia. Because a substantial number of 
patients also develop pneumonia after hospital discharge, there is a need for identify-
ing additional factors that are associated with pneumonia beyond hospital discharge.4
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Low estimated glomerular filtration rate (eGFR) (ie, <60 
mL/min/1.73 m2) is shown to be associated with pneumo-
nia in general population, thought to be due to a weakened 
immune system in patients with kidney disease.7–10 However, 
whether there is a link between eGFR levels and pneumonia 
in patients with stroke has not yet been thoroughly exam-
ined. This is important because a better understanding of 
factors related to pneumonia in stroke patients could inform 
clinicians to better identify those with increased risk, thus 
enabling them to offer appropriate management of this com-
mon complication.
In this prospective cohort registry of stroke patients, we 
aimed to examine the association between eGFR and occur-
rence of in-hospital and after hospital discharge pneumonia. 
For a thorough assessment, we aimed to examine these 
associations when eGFR is categorized as per recommended 
clinical guidelines11 stratified by aspiration and nonaspira-
tion pneumonia.
Patients and methods
Sample population
We used the data from the Norfolk and Norwich Stroke 
Registry that has data on patients with a diagnosis of acute 
stroke admitted to Norfolk and Norwich University Hospital 
since 1996. The hospital hosts the only acute stroke unit for a 
population of ~750,000 inhabitants in the city of Norwich and 
surrounding rural areas of Norfolk, UK. All patients included 
in the register were reviewed and diagnosed by a specialist 
stroke team. Methods of data collection of the register have 
been described elsewhere.12 In summary, paper-based patient 
data were reviewed and entered onto the register database by 
the hospital stroke data team. Register database was linked 
with electronic health records.13 Accessed data were deidenti-
fied. Ethical approval was obtained from the Newcastle and 
Tyneside National Health Service (NHS) Research Ethics 
Committee (Approval number: 12/NE/0170), and the study 
protocol was approved by the Steering Committee of the 
Norfolk and Norwich Stroke Register.
A total of 10,683 stroke patients (age ≥18 years) with 
either ischemic or hemorrhagic stroke were admitted to 
the hospital between January 2003 and April 30, 2015. 
Patients were included from the beginning of 2003 since 
biochemistry data were electronically available only after 
January 2003. We excluded patients with missing infor-
mation of serum creatinine (n=354). There was complete 
information on comorbidities, and we selected relevant 
cardiovascular and respiratory comorbidities including dia-
betes, hypertension, dyslipidemia, coronary heart disease, 
atrial fibrillation, heart failure, asthma, COPD, and lung 
cancer. The final analytic sample thus comprised 10,329 
stroke patients.
eGFR
The serum creatinine level was measured twice (on admis-
sion and discharge) using the Jaffe method and standardized 
to isotype dilution mass spectrometry values. The Chronic 
Kidney Disease – Epidemiology collaboration equation was 
used to estimate kidney function.14 Although data for race 
were not available, misclassification of eGFR was expected 
to be minimal because <2% of the Norwich population is 
of non-white northern European ethnic origin.15 Low eGFR 
was defined as eGFR<60 mL/min/1.73 m2. Because our main 
objective was to investigate eGFR across its entire range of 
clinically relevant categories, eGFR was divided into all clini-
cally relevant categories and subjects in all categories were 
included in the analysis. eGFR was categorized into follow-
ing levels: <15, 15–29, 30–44, 45–59, 60–89, and ≥90 mL/
min/1.73 m2, according to the new classification for kidney 
function assessment and management.11
Pneumonia
The primary outcomes of the study were in-hospital pneu-
monia and pneumonia occurring after hospital discharge. 
Pneumonia cases were identif ied using International 
 Classification of Disease (ICD)-10th revision code: J69 for 
aspiration pneumonia, J12 for viral, J13 for streptococcal, 
J14 for haemophilus influenza, J15 for bacterial, J16 for other 
infectious organism, J17 for pneumonia in disease classified 
elsewhere, and J18 for pneumonia organism unspecified. 
Stroke patients developing pneumonia after hospital dis-
charge were identified from record linkage with NHS Patient 
Administrative System that captures all diagnosis codes in 
the community as well as hospitalized pneumonias. Associa-
tions were also examined when pneumonia (both in-hospital 
and after hospital discharge) was subdivided into aspiration 
and nonaspiration pneumonia. Patients were followed until 
May 30, 2015 so as to have minimal follow-up of 1 month.
Other covariates
Data on age (years), sex (male/female), history of stroke 
(yes/no), stroke type (ischemic or hemorrhagic), prestroke 
modified Rankin score (mRS) (modified by the UK tran-
sient ischemic attack investigators) (0–5), and Oxfordshire 
Community Stroke Project Classification were collected by 
specialist stroke nurses or doctors. For each patient, when 
admitted, data on the pre-stroke mRS16 were collected from 
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nursing and medical records. Comorbidity (yes/no) data were 
obtained through record linkage and included relevant major 
comorbid conditions as described above.
Statistical analysis
Characteristics of study subjects were presented for overall 
study population and by low eGFR status (yes/no). Differ-
ences in characteristics across levels of eGFR were compared 
using Two-sample t-test for continuous variables (Wilcoxon 
Rank-Sum Test for nonnormally distributed variables) and 
χ2 test for categorical variables. Characteristics of study sub-
jects were also reported by all clinically relevant categories 
of eGFR. Distribution of eGFR by pneumonia status was 
assessed using kernel-density distribution plots. Because 
death could be a competing risk in the risk for pneumonia 
development, competing risk regression analysis (using Fine 
and Gray method) was performed to calculate subdistribu-
tion hazard ratio (sHR) and 95% confidence intervals (CIs) 
for the association of low eGFR and eGFR categorized as 
per Kidney Disease: Improving Global Outcomes guidelines 
(eGFR ≥90 mL/min/1.73 m2 as the reference group) with in-
hospital pneumonia and pneumonia after hospital discharge. 
Additionally, association was also examined when pneumonia 
(both in-hospital and after hospital discharge) was subdivided 
into aspiration and nonaspiration type pneumonia.
Multiple models were constructed to adjust for potential 
confounders. Model 1 was adjusted for demographic fac-
tors (ie, age and sex). Model 2 was additionally adjusted for 
factors related to stroke (ie, history of stroke, stroke type, 
Oxfordshire Community Stroke Project [stroke severity], 
and pre-stroke mRS). In Model 3, co-existing respiratory 
illnesses (eg, asthma, COPD and lung cancer) and in Model 
4 other comorbid conditions (ie, diabetes, hypertensions, 
dyslipidemia, coronary heart disease, arterial fibrillation, and 
heart failure) were added. To examine whether association 
between eGFR and pneumonia varies across high-risk sub-
groups, we calculated interaction for age (<80 years and ≥80 
years), sex (male/female), pre-stroke mRS level (<3 and ≥3), 
and diabetes status (no/yes). We additionally investigated the 
interaction between eGFR and stroke type. To avoid highly 
correlated predictor variables, 2-way correlations between the 
predictor variables were assessed using Pearson’s correlation 
coefficient. Model goodness-of-fit was assessed using the 
goodness-of-fit test using mlogitgof (for multinomial logistic 
regression)17 and fitstat (for logistic regression)18 commands 
in Stata/SE 14.0 (StataCorp LLC, College Station, TX, USA).
Multiple imputation was performed by chained equations 
with 10 iterations to impute missing data (previous stroke 
[n=253; 2.4%], stroke severity [n=631; 6.1%], and pre-stroke 
modified Rankin score [n=674; 6.5%]).19,20 The following vari-
ables were incorporated into the model for imputations: age, 
sex, history of stroke, stroke type, serum creatinine, asthma, 
COPD, lung cancer, diabetes, hypertension, dyslipidemia, 
heart failure, atrial fibrillation, and coronary heart disease.
Additional analyses
To further evaluate the association between eGFR and 
pneumonia, we performed a number of additional analyses. 
First, to examine the size and shape of association across 
range of eGFR levels, we explored the association between 
eGFR distribution and pneumonia by dividing eGFR into 
groups spanning 15 mL/min/1.73 m2: <15, 15–29, 30–44, 
45–59, 60–74, 75–89, 90–105 (reference), and >105 mL/
min/1.73 m2. Second, a single measurement of serum 
creatinine may not be accurate in assessing kidney func-
tion. We used a second measurement of serum creatinine 
that was performed at hospital discharge and examined 
association between eGFR and pneumonia after excluding 
those at top and bottom 25th percentile of the difference in 
eGFR (per day of hospital stay) between hospital admission 
and discharge. Third, patients were enrolled in our study 
between 2003 and 2015 (ie, over a period of 12.3 years). To 
account for potential change in stroke management practice 
over time which may affect occurrence of pneumonia in 
stroke patients, we examined association between eGFR 
and pneumonia separately for patients admitted between 
years 2003–2007, 2007–2011, and 2011–2015. Fourth, we 
investigated the association between eGFR and pneumonia 
among those patients who previously did not have stroke. All 
analyses in the study were performed according to analytical 
plan developed at the start of the study.
Results
Sample characteristics
Characteristics of the sample population are presented accord-
ing to low eGFR status in Table 1. Compared to patients with 
high eGFR, patients with low eGFR were often older, females, 
had previous history of stroke, and had high prestroke mRS. 
Larger proportion of patients in the low eGFR group had 
ischemic stroke, COPD, diabetes, hypertension, and most car-
diovascular diseases including coronary heart disease, heart 
failure, and arterial fibrillation. The prevalence of dyslipid-
emia and lung cancer was higher in high eGFR group, whereas 
there was no statistically significant difference in prevalence 
of asthma between two groups. Median length of hospital 
stay was higher in patients with low eGFR compared to high 
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eGFR. Characteristics of the sample population according 
to all clinically relevant categories of eGFR are presented in 
Table S1. Generally, prevalence of comorbidities increased 
with decline in level of eGFR. A total of 157 (1.5%) patients 
were on dialysis or were eligible for dialysis.
In our sample, 1,519 (14.7%) developed in-hospital 
pneumonia and 1,037 (12.9%) developed pneumonia after 
hospital discharge. After hospitalization for stroke, median 
day of in-hospital pneumonia diagnosis was 0 (interquartile 
interval: 0–1) and after hospital discharge pneumonia diag-
nosis was 708 (interquartile interval: 232–1,562). Prevalence 
of pneumonia, both in-hospital and after hospital discharge, 
was higher in patients with low eGFR compared to patients 
with high eGFR (p<0.001) (Table 2). eGFR was shifted 
toward lower values among pneumonia patients (Figure S1). 
Mean eGFR was 65±22, 58±22, and 63±21 mL/min/1.73 m2 
in patients without pneumonia, in-hospital pneumonia, and 
after hospital discharge pneumonia, respectively.
Association between eGFR and 
pneumonia
In age- and sex-adjusted model (Model 1), low eGFR was 
associated with in-hospital pneumonia (sHR: 1.13; 95% CI: 
1.00–1.29) and pneumonia after discharge (sHR: 1.20; 95% 
CI: 1.07–1.38). With further adjustment for stroke-related 
factors and comorbidities, association was attenuated for 
in-hospital pneumonia but remained statistically significant 
for pneumonia after hospital discharge (Table 2). Association 
of eGFR with in-hospital pneumonia existed particularly for 
aspiration pneumonia and with pneumonia after hospital 
discharge existed for nonaspiration pneumonia (Table 2). No 
interaction was observed for age (<80 years and ≥80 years), 
sex (male/female), prestroke mRS level (<3 and ≥3), diabetes 
status (no/yes), and stroke type (Table S2).
eGFR, categorized as per KDIGO guidelines, showed 
a “U” shaped association with occurrence of in-hospital 
pneumonia. For instance, in age- and sex-adjusted model, 
Table 1 Characteristics of sample population by low eGFR
Characteristics Overall (N=10,329) Low eGFR (<60 mL/min/1.73 m2)
No (n=5,972) Yes (n=4,357)
Age (years) 77.8±11.9 74.1±12.5 82.8±8.7
Sex (male) 47.5 (4,902) 51.8 (3,096) 41.5 (1,806)
Stroke history,a % (n) 24.6 (2,474) 21.9 (1,273) 28.2 (1,201)
Stroke type (ischemic), % (n) 86.6 (8,942) 84.1 (5,024) 89.9 (3,918)
OSCP classificationa
TACS 20.9 (2,028) 18.8 (1,048) 14.1 (581)
PACS 33.2 (3,215) 32.4 (1,802) 34.2 (1,413)
LACS 22.6 (2,188) 23.8 (1,325) 20.9 (863)
POCS 16.8 (1,629) 18.8 (1,048) 14.1 (581)
Other 6.6 (638) 6.2 (345) 7.0 (293)
Prestroke mRSa
0 63.3 (6,113) 69.5 (3,920) 54.7 (2,193)
1 12.1 (1,167) 11.9 (669) 12.4 (498)
2 8.2 (794) 7.1 (400) 9.8 (394)
3 9.5 (918) 6.8 (385) 13.3 (533)
4 4.8 (466) 3.4 (193) 6.8 (273)
5 2.0 (197) 1.3 (76) 3.0 (121)
Diabetes, % (n) 14.6 (1,505) 12.6 (755) 17.2 (750)
Hypertension, % (n) 51.8 (5,354) 48.1 (2,870) 57.0 (2,484)
Dyslipidemia, % (n) 10.3 (1,062) 11.0 (657) 9.3 (405)
Coronary heart disease, % (n) 23.4 (2,417) 18.7 (1,115) 29.9 (1,302)
Heart failure, % (n) 11.8 (1,219) 7.4 (439) 17.9 (780)
Atrial fibrillation,% (n) 26.9 (2,786) 22.1 (1,317) 33.7 (1,469)
COPD, % (n) 6.9 (720) 6.4 (381) 7.9 (339)
Asthma, % (n) 8.0 (826) 8.4 (504) 7.4 (322)
Lung cancer, % (n) 0.8 (85) 1.0 (61) 0.6 (24)
Length of stay (days) 8 (4–18) 7 (3–15) 10 (4–20)
Notes: Continuous variables with normal distribution are presented as mean ±SD and nonnormal distribution are presented as median (interquartile interval); categorical 
variables are presented as percentages (n); a253 participants missing information on previous stroke, 631 on OSCP classification and 674 on mRS.
Abbreviations: eGFR, estimated glomerular filteration rate; OSCP, Oxfordshire Community Stroke Project; TACS, total anterior circulation stroke; PACS, partial anterior 
circulation stroke; LACS, lacunar stroke; POCS, posterior circulation stroke; mRS, modified Rankin score.
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sHR for the association were 0.75 (95% CI: 0.60–0.95), 0.76 
(95% CI: 0.58–0.97), 0.89 (95% CI: 0.68–1.16), 0.99 (95% 
CI: 0.74–1.33), and 1.24 (95% CI: 0.82–1.85) for eGFR level 
60–89, 45–59, 30–44, and <30 mL/min/1.73 m2 respectively, 
(compared to eGFR ≥90 mL/min/1.73 m2) (Table 3). Asso-
ciation with pneumonia after hospital discharge, however, 
showed an inverse dose–response relationship such that with 
declining eGFR level likelihood of pneumonia after hospital 
discharge increased. For example, in age- and sex-adjusted 
model, compared to eGFR ≥90 mL/min/1.73 m2, sHR of 
pneumonia after hospital discharge were 1.13 (0.84–1.52), 
1.18 (0.86–1.63), 1.39 (0.99–1.96), 1.94 (1.32–2.86), and 
2.33 (1.24–4.38) for eGFR level 60–89, 45–59, 30–44, and 
<30 mL/min/1.73 m2, respectively (Table 4). Further adjust-
ment for potential confounders did not alter trend of their 
association (Tables 3 and 4). Similar to the association with 
low eGFR, association in case of in-hospital pneumonia 
existed particularly for aspiration pneumonia (Table 3) and 
in case of pneumonia after hospital discharge existed for 
nonaspiration pneumonia (Table 4).
Additional analyses
When eGFR was divided into groups spanning 15 mL/
min/1.73 m2, the size and shape of association with pneumo-
nia corroborated with the association for eGFR divided into 
recommended clinically relevant categories (Figure 1). After 
excluding those with top and bottom 25th percentile of the 
difference in estimated kidney function between admission 
and discharge, the pattern of association between eGFR and 
pneumonia was similar to our main results (Table S3). In 
addition, results for examining years 2003–2006, 2007–2011, 
and 2011–2015 separately were similar to overall findings 
(Table S4). When examining only those who did not have 
stroke previously, the association between low eGFR and 
pneumonia was in line with our overall findings (Table S5). 
Discussion
In this large prospective cohort of unselected stroke patients, 
we found that there was a modest association between low 
eGFR and occurrence of pneumonia both in-hospital and 
after hospital discharge. These associations were rather 
strong when analyzed across all clinically relevant categories 
of eGFR. The association between eGFR and in-hospital 
pneumonia tended to be “U” shaped such that, compared 
to eGFR ≥90 mL/min/1.73 m2, patients with eGFR 60–89 
and 45–59 mL/min/1.73 m2 were at lower risk of in-hospital 
pneumonia, whereas patients with eGFR <30 mL/min/1.73 
m2 had similar risk. Risk of pneumonia after hospital dis-
charge, however, increased with declining eGFR such that 
patients with eGFR <30 mL/min/1.73 m2 had an almost 
twofold higher risk compared to patients with eGFR ≥90 
mL/min/1.73 m2. Association for in-hospital pneumonia 
was mainly evident for aspiration type pneumonia, whereas 
association with pneumonia after hospital discharge was 
evident for nonaspiration type pneumonia.
Table 2 Association between low eGFR and pneumonia in 
stroke patients
Pneumonia type Low eGFR (<60 mL/min/1.73 m2)
No Yes
In-hospital n=5,972 n=4,357
Overall (sHR; 95% CI)
Events, % (n) 12.2 (727) 18.2 (792)
Model 1 Ref. [1] 1.13 (1.00–1.29)
Model 2 Ref. [1] 1.10 (0.97–1.26)
Model 3 Ref. [1] 1.10 (0.96–1.25)
Model 4 Ref. [1] 1.07 (0.94–1.22)
Aspiration (sHR; 95% CI)
Events, % (n) 7.4 (441) 11.3 (491)
Model 1 Ref. [1] 1.15 (1.01–1.32)
Model 2 Ref. [1] 1.11 (0.95–1.26)
Model 3 Ref. [1] 1.10 (0.96–1.26)
Model 4 Ref. [1] 1.07 (0.93–1.23)
Nonaspiration (sHR; 95% CI)
Events, % (n) 4.8 (286) 6.9 (301)
Model 1 Ref. [1] 1.10 (0.93–1.32)
Model 2 Ref. [1] 1.06 (0.89–1.26)
Model 3 Ref. [1] 1.05 (0.88–1.26)
Model 4 Ref. [1] 1.03 (0.86–1.23)
After hospital dischargea n=5,219 n=2,802
Overall (sHR; 95% CI)
Events, % (n) 11.3 (589) 16.0 (448)
Model 1 Ref. [1] 1.20 (1.07–1.38)
Model 2 Ref. [1] 1.18 (1.04–1.34)
Model 3 Ref. [1] 1.18 (1.03–1.37)
Model 4 Ref. [1] 1.15 (1.01–1.30)
Aspiration, % (n) (sHR; 95% CI)
Events 4.2 (220) 4.7 (132)
Model 1 Ref. [1] 0.96 (0.75–1.23)
Model 2 Ref. [1] 0.95 (0.74–1.22)
Model 3 Ref. [1] 0.93 (0.73–1.19)
Model 4 Ref. [1] 0.92 (0.72–1.18)
Nonaspiration, % (n) (sHR; 95% CI)
Events 7.1 (369) 11.3 (316)
Model 1 Ref. [1] 1.37 (1.15–1.65)
Model 2 Ref. [1] 1.31 (1.10–1.58)
Model 3 Ref. [1] 1.31 (1.10–1.59)
Model 4 Ref. [1] 1.28 (1.08–1.54)
Notes: Model 1: age, sex. Model 2: Model 1+history of stroke, stroke type, 
prestroke modified Rankin score, Oxfordshire Community Stroke Project (stroke 
severity). Model 3: Model 2+asthma, COPD, lung cancer. Model 4: Model 3+diabetes, 
hypertension, dyslipidemia, coronary heart disease, heart failure, arterial fibrillation. 
aIn patients that were alive at discharge (N=8,021).
Abbreviations: eGFR, estimated glomerular filtration rate; RRR, relative risk ratio; 
sHR, ; .
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Several recent studies have examined the association 
between reduced kidney function and risk of infections 
including pneumonia in the general population and showed 
increased risk of pneumonia with declining kidney func-
tion.7,21,22 To our knowledge, this is the first study to formally 
examine the association between eGFR and pneumonia 
in stroke patients. This study therefore expands current 
knowledge in a number of ways. First, our study shows that 
eGFR may be a risk marker (or a risk factor) for pneumonia 
in stroke patients, particularly for after hospital discharge 
Table 3 Association between level of eGFR and in-hospital pneumonia in stroke patients
Pneumonia 
type
Level of eGFR (mL/min/1.73 m2)
≥90 (n=1,106) 60–89 (n=4,866) 45–59 (n=2,177) 30–44 (n=1,427) 15–29 (n=596) <15 (n=157)
Overall (sHR; 95% CI)
Events, % (n) 8.6 (96) 13.0 (631) 15.7 (342) 20.0 (285) 21.0 (131) 21.7 (34)
Model 1 Ref. [1] 0.75 (0.60–0.95) 0.76 (0.58–0.97) 0.89 (0.68–1.16) 0.99 (0.74–1.33) 1.24 (0.82–1.85)
Model 2 Ref. [1] 0.80 (0.65–1.00) 0.80 (0.62–1.03) 0.93 (0.72–1.22) 0.96 (0.72–1.29) 1.15 (0.77–1.73)
Model 3 Ref. [1] 0.79 (0.63–0.99) 0.78 (0.61–1.00) 0.92 (0.71–1.20) 0.94 (0.70–1.26) 1.12 (0.75–1.68)
Model 4 Ref. [1] 0.78 (0.62–0.99) 0.76 (0.59–0.99) 0.89 (0.68–1.16) 0.90 (0.66–1.20) 1.06 (0.71–1.60)
Aspiration (sHR; 95% CI)
Events, % (n) 5.7 (63) 7.8 (378) 10.7 (232) 11.5 (164) 12.8 (76) 12.1 (19)
Model 1 Ref. [1] 0.67 (0.50–0.89) 0.75 (0.55–1.03) 0.76 (0.54–1.06) 0.86 (0.60–1.25) 1.05 (0.62–1.78)
Model 2 Ref. [1] 0.71 (0.53–0.96) 0.79 (0.57–1.08) 0.80 (0.57–1.11) 0.84 (0.58–1.22) 0.99 (0.58–1.68)
Model 3 Ref. [1] 0.71 (0.53–0.96) 0.78 (0.57–1.07) 0.79 (0.57–1.10) 0.83 (0.57–1.20) 0.97 (0.57–1.65)
Model 4 Ref. [1] 0.69 (0.52–0.93) 0.75 (0.55–1.04) 0.76 (0.54–1.05) 0.77 (0.53–1.12) 0.90 (0.53–1.54)
Nonaspiration (sHR; 95% CI)
Events, % (n) 2.9 (33) 5.2 (253) 5.1 (110) 8.5 (121) 9.2 (55) 9.6 (15)
Model 1 Ref. [1] 0.89 (0.60–1.32) 0.73 (0.47–1.12) 1.14 (0.74–1.76) 1.27 (0.79–2.05) 1.6 (0.89–3.16)
Model 2 Ref. [1] 0.98 (0.66–1.45) 0.79 (0.51–1.22) 1.21 (0.78–1.87) 1.22 (0.76–1.96) 1.51 (0.80–2.85)
Model 3 Ref. [1] 0.97 (0.65–1.43) 0.78 (0.50–1.20) 1.19 (0.77–1.83) 1.19 (0.74–1.91) 1.46 (0.78–2.76)
Model 4 Ref. [1] 0.96 (0.65–1.43) 0.76 (0.50–1.18) 1.16 (0.75–1.80) 1.13 (0.70–1.84) 1.42 (0.75–2.68)
Notes: Model 1: age, sex. Model 2: Model 1+history of stroke, stroke type, prestroke modified Rankin score, Oxfordshire Community Stroke Project (stroke severity). 
Model 3: Model 2+asthma, COPD, lung cancer. Model 4: Model 3+diabetes, hypertension, dyslipidemia, coronary heart disease, heart failure, arterial fibrillation.
Abbreviations: eGFP, estimated glomerular filtration rate; RRR, relative risk ratio; sHR, subdistribution hazard ratio.
Table 4 Association between level of eGFR and pneumonia after discharge in stroke patientsa
Pneumonia 
type
Level of eGFR (mL/min/1.73 m2)
≥90 (n=1,086) 60–89 (n=4,133) 45–59 (n=1,544) 30–44 (n=914) 15–29 (n=282) <15 (n=62)
Overall (sHR; 95% CI)
Events, % (n) 7.5 (82) 12.3 (507) 14.7 (227) 16.4 (150) 21.3 (60) 17.7 (11)
Model 1 Ref. [1] 1.13 (0.84–1.52) 1.18 (0.86–1.63) 1.39 (0.99–1.96) 1.94 (1.32–2.86) 2.33 (1.24–4.38)
Model 2 Ref. [1] 1.18 (0.88–1.59) 1.24 (0.90–1.71) 1.44 (1.02–2.02) 1.90 (1.29–2.79) 2.09 (1.11–3.96)
Model 3 Ref. [1] 1.17 (0.87–1.58) 1.25 (0.91–1.73) 1.41 (1.00–1.98) 1.84 (1.25–2.72) 2.07 (1.15–4.11)
Model 4 Ref. [1] 1.11 (0.83–1.50) 1.16 (0.84–1.61) 1.30 (0.92–1.83) 1.55 (1.05–2.29) 1.85 (1.01–3.51)
Aspiration (sHR; 95% CI)
Events, % (n) 3.0 (33) 4.5 (187) 4.7 (73) 4.5 (41) 5.7 (16) 3.2 (2)
Model 1 Ref. [1] 1.15 (0.69–1.92) 1.22 (0.70–2.12) 1.24 (0.69–2.25) 1.61 (0.81–3.18) 0.58 (0.08–4.38)
Model 2 Ref. [1] 1.25 (0.75–2.09) 1.35 (0.78–2.35) 1.34 (0.74–2.42) 1.61 (0.81–3.18) 0.48 (0.06–3.64)
Model 3 Ref. [1] 1.23 (0.74–2.05) 1.36 (0.78–2.36) 1.32 (0.73–2.39) 1.53 (0.77–3.04) 0.50 (0.07–3.82)
Model 4 Ref. [1] 1.20 (0.72–2.00) 1.28 (0.73–2.22) 1.24 (0.68–2.24) 1.30 (0.65–2.61) 0.44 (0.06–3.32)
Nonaspiration (sHR; 95% CI)
Events, % (n) 4.5 (49) 7.7 (320) 9.9 (154) 11.9 (109) 15.6 (44) 14.5 (9)
Model 1 Ref. [1] 1.13 (0.79–1.63) 1.20 (0.81–1.77) 1.51 (0.99–2.29) 2.22 (1.39–3.54) 3.37 (1.70–6.70)
Model 2 Ref. [1] 1.16 (0.81–1.67) 1.21 (0.82–1.80) 1.52 (1.00–2.30) 2.10 (1.31–3.37) 3.09 (1.55–6.16)
Model 3 Ref. [1] 1.15 (0.80–1.65) 1.23 (0.83–1.82) 1.48 (0.98–2.25) 2.05 (1.28–3.28) 3.17 (1.59–6.31)
Model 4 Ref. [1] 1.08 (0.75–1.56) 1.12 (0.76–1.67) 1.36 (0.89–2.07) 1.69 (1.05–2.72) 2.66 (1.33–5.33)
Notes: Model 1: age, sex. Model 2: Model 1+history of stroke, stroke type, prestroke modified Rankin score, Oxfordshire Community Stroke Project (stroke severity). 
Model 3: Model 2+asthma, COPD, lung cancer. Model 4: Model 3+diabetes, hypertension, dyslipidemia, coronary heart disease, heart failure, arterial fibrillation. aIn patients 
that were alive at discharge (N=8,021).
Abbreviations: eGFR, estimated glomerular filtration rate; RRR, relative risk ratio; sHR, subdistribution hazard ratio.
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pneumonia. The association between eGFR and after hospital 
discharge pneumonia suggests that low eGFR is a risk factor 
for community-acquired pneumonia also in stroke survivors. 
This is important given that pneumonia incidence is high in 
stroke patients and is the major cause of mortality in these 
patients. Second, our results suggest that similar to its rela-
tionship with mortality, creatinine-based eGFR may have a 
nonlinear relationship with pneumonia during hospital stay 
Figure 1 Subdistribution HRs with 95% CIs for the association between eGFR and pneumonia.
Notes: (A) Overall; (B) aspiration; (C) nonaspiration, for in-hospital pneumonia; (D) overall; (E) aspiration; (F) nonaspiration, for pneumonia after hospital discharge. 
Subdistribution HR are presented according to the level of eGFR categorized by 15 mL/min/1.73 m2 difference, with eGFR of 90–105 mL/min/1.73 m2 serving as the reference group.
Abbreviations: eGFR, estimated glomerular filtration rate; HR, Hazard ratio.
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in stroke patients. Finally, we show that during hospital stay 
it is aspiration type pneumonia and after discharge nonaspira-
tion type pneumonia that is likely to be related to low eGFR.
We did not observe an independent association between 
reduced eGFR, ie, <60 mL/min/1.73 m2, and in-hospital 
pneumonia, which in line with a previous study.23 However, 
when this association was examined for all clinically relevant 
categories of eGFR (with eGFR <90 mL/min/1.73 m2 as 
reference), eGFR appeared to be associated with in-hospital 
pneumonia also in fully adjusted model. Statistical power of 
these analyses was adequate, ie, 76% and 83% for smallest 
eGFR category, ie, <15 (vs ≥90) mL/min/1.73 m2, in case 
of in-hospital pneumonia and pneumonia after hospital dis-
charge, respectively. Minor to moderate association observed 
between low eGFR (<60 mL/min/1.73 m2) and pneumonia is 
likely because of collapsing all clinically relevant categories 
in just two categories that can obscure the true nature of the 
association. This was evident when eGFR was examined 
across all clinically relevant categories where categories with 
modest association are larger while categories with rather 
strong association were smaller (Tables 3 and 4).
Similar to the association between eGFR and mortal-
ity, a “U” shaped association was observed between eGFR 
and in-hospital pneumonia in stroke patients, (suggesting 
increased risk at eGFR of ≥90 mL/min/1.73 m2) (Figure 
1). This is likely due to overestimation of eGFR in severely 
ill (or those with multiple comorbidities) patients as these 
patients generally are at high risk of in-hospital pneumonia 
and death. Severely ill patients are likely to have reduced 
muscle mass and, consequently, low serum levels of creatinine 
and high eGFR.24 Of note, prestroke disability was higher 
among in-hospital pneumonia compared to after hospital 
discharge pneumonia cases (mRS >3: 27% vs 16%, p<0.001) 
and association attenuated after adjusting for comorbidities. 
Moreover, association between eGFR and in-hospital pneu-
monia existing particularly for aspiration type pneumonia 
(which more often occurs in patients with increased prestroke 
disability25) corroborated with this assumption. Thus, in case 
of in-hospital pneumonia, eGFR may not be causally related 
and instead is an indicator of frailty or reduced muscle mass 
due to illness, which themselves are related to in-hospital 
pneumonia. On the other hand, patients that were discharged 
from hospital probably had improved physical condition, and 
thus creatinine in these patients provided a more accurate 
assessment of their eGFR and a more realistic assessment 
of nature of the association between eGFR and pneumonia. 
As a result, eGFR tended to show a liner association such 
that with declining kidney function risk for pneumonia after 
hospital discharge increased. Among others, stroke-induced 
immunodepression may also explain link between eGFR and 
pneumonia in stroke patients. However, as an epidemiologi-
cal record linkage study, we were not able to examine the 
contribution of such a pathophysiological link.
Pneumonia is associated with a number of adverse out-
comes including death and functional disability in stroke 
patients (as also observed in our study, Tables S6 and S7). 
Thus, our findings may have a number of clinical and research 
implications. Given that the association between eGFR and 
pneumonia is independent of most known risk factors for 
pneumonia, our findings suggest that eGFR, especially when 
severely reduced, may be used as an early marker to identify 
high-risk patients for pneumonia. Future studies developing 
prediction model for pneumonia in stroke patients may con-
sider eGFR as a one of the prognostic factors while model 
selection. In case of in-hospital pneumonia, our findings 
suggest caution in interpreting high eGFR values as these 
values may not mean better kidney function and less likeli-
hood of pneumonia. Thus, patients with both high eGFR 
(when estimated using serum creatinine) and low eGFR 
may be targeted for in-hospital pneumonia prevention. For 
pneumonia after hospital discharge, patients with severely 
reduced eGFR may be recommended for vaccination against 
pneumonia. Our study also provides possible role of optimiz-
ing renal function in stroke patients, eg, avoiding drugs that 
can result in impaired renal function such as nonsteroidal 
anti-inflammatory drugs, and some antibiotics eg, trim-
ethoprim, used to treat urinary tract infection which is also 
prevalent in stroke, to reduce the risk of stroke associated 
pneumonia. Whether or not eGFR can be a therapeutic target 
to reduce pneumonia risk in stroke patients may require fur-
ther investigation if causality is established in future studies. 
Importantly, future studies are required to examine the eGFR 
in-hospital pneumonia association when estimating kidney 
function from biomarkers that are less dependent on muscle 
mass (eg, Cystatin C, β microglobulin).26,27
It is important to acknowledge limitations of present 
study. First, in this study, we used serum creatinine to estimate 
kidney function. Serum creatinine may overestimate eGFR in 
severely ill patients.28 Thus, other biomarkers of kidney func-
tion that are less dependent on muscle mass (eg, cystatin C) 
may be required for more accurate estimation of kidney 
function in this group.29 However, serum creatinine is most 
commonly used biomarker for GFR estimation in clinical 
practice, and thus our findings reflect a real-world scenario. 
Second, it is possible that we did not capture all strokes such 
as those assessed in outpatient care.  Nevertheless, truncation 
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of distribution is only likely to contribute to attenuation of 
results due to reduced sample size. Third, we lacked infor-
mation on some potentially relevant factors (eg, National 
Institute of Health Stroke Scale, dysphagia, dysarthria, body 
mass index, and lesion characteristics). Thus, we were unable 
to explore role of these factors. Fourth, pneumonia was 
ascertained from ICD codes, alone which may have resulted 
in misclassification of some pneumonia cases. However, ICD 
codes are shown as a valid tool for identification of pneu-
monia, particularly in hospitalized patients.30,31 Upon further 
investigation in our study, C-reactive protein levels were also 
found to be high in identified pneumonia cases (44.9 mg/dL 
vs 28.8 mg/dL, p<0.001), suggesting less likelihood of such 
misclassification bias. Finally, it is possible that impairment 
of renal function is result of a number of other chronic dis-
eases and the association between eGFR and pneumonia is 
due to confounding from other unmeasured comorbidities. 
However, it should also be noted that the aim of this study 
was not to establish causation but to investigate the associa-
tion between eGFR and pneumonia, which may be useful in 
providing additional risk marker for poststroke pneumonia.
This study has a number of strength. Our large sample 
population allowed us to conduct a rigorous analysis so as to 
examine the size and shape of the association between eGFR 
and pneumonia across all clinically relevant categories of eGFR. 
Furthermore, the availability of information on stroke-related 
factors, respiratory conditions, and a wide range of comorbidi-
ties allowed us to adjust for a number of relevant factors and 
therefore minimize the effects of confounding. As a study using 
data from a hospital-based disease register, the patient popula-
tion under evaluation represents real-world clinical events.
Conclusion
Our findings suggest that low eGFR (<60 mL/min/1.73 m2) 
is modestly while severely reduced eGFR (<30 mL/
min/1.73 m2) is strongly associated with pneumonia in stroke 
patients. Association with in-hospital pneumonia tended to 
be “U” shaped and postdischarge pneumonia appeared to be 
linear. Our data suggest that eGFR may be useful in planning 
prevention and management of hospital-based (for in-hospital 
pneumonia) and community-based (for pneumonia after 
discharge) pneumonia among stroke patients.
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